Findings hold promise for developing regenerative therapies for spinal cord injuries and diseases such as multiple sclerosis
Stem cell technology has long offered the hope of regenerating tissue to repair broken or damaged neural tissue. Findings from a team of UC Davis investigators have brought this dream a step closer by developing a method to generate functioning brain cells that produce myelin — a fatty, insulating sheath essential to normal neural conduction.
“Our findings represent an important conceptual advance in stem cell research,” said Wenbin Deng, principal investigator of the study and associate professor at the UC Davis Department of Biochemistry and Molecular Medicine. “We have bioengineered the first generation of myelin-producing cells with superior regenerative capacity.”
The brain is made up predominantly of two cell types: neurons and glial cells. Neurons are regarded as responsible for thought and sensation. Glial cells surround, support and communicate with neurons, helping neurons process and transmit information using electrical and chemical signals. One type of glial cell — the oligodendrocyte — produces a sheath called myelin that provides support and insulation to neurons. Myelin, which has been compared to insulation around electrical wires that helps to prevent short circuits, is essential for normal neural conduction and brain function; well-recognized conditions involving defective myelin development or myelin loss include multiple sclerosis and leukodystrophies.
In this study, the UC Davis team first developed a novel protocol to efficiently induce embryonic stem cells (ESCs) to differentiate into oligodendroglial progenitor cells (OPCs), early cells that normally develop into oligodendrocytes. Although this has been successfully done by other researchers, the UC Davis method results in a purer population of OPCs, according to Deng, with fewer other cell types arising from their technique.
They next compared electrophysiological properties of the derived OPCs to naturally occurring OPCs. They found that unlike natural OPCs, the ESC-derived OPCs lacked sodium ion channels in their cell membranes, making them unable to generate spikes when electrically stimulated. Using a technique called viral transduction, they then introduced DNA that codes for sodium channels into the ESC-derived OPCs. These OPCs then expressed ion channels in their cells and developed the ability to generate spikes.
According to Deng, this is the first time that scientists have successfully generated OPCs with so-called spiking properties. This achievement allowed them to compare the capabilities of spiking cells to non-spiking cells.
In cell culture, they found that only spiking OPCs received electrical input from neurons, and they showed superior capability to mature into oligodendrocytes.
They also transplanted spiking and non-spiking OPCs into the spinal cord and brains of mice that are genetically unable to produce myelin. Both types of OPCs had the capability to mature into oligo-dendrocytes and produce myelin, but those from spiking OPCs produced longer and thicker myelin sheaths around axons.
“We actually developed ‘super cells’ with an even greater capacity to spike than natural cells,” Deng said. “This appears to give them an edge for maturing into oligodendrocytes and producing better myelin.”
It is well known that adult human neural tissue has a poor capacity to regenerate naturally. Although early cells such as OPCs are present, they do not regenerate tissue very effectively when disease or injury strikes.
Deng believes that replacing glial cells with the enhanced spiking OPCs to treat neural injuries and diseases has the potential to be a better strategy than replacing neurons, which tend to be more problematic to work with. Providing the proper structure and environment for neurons to live may be the best approach to regenerate healthy neural tissue. He also notes that many diverse conditions that have not traditionally been considered to be myelin-related diseases – including schizophrenia, epilepsy and amyotrophic lateral sclerosis (ALS) – actually are now recognized to involve defective myelin.
The Latest Bing News on:
Stem cell technology
- England fan skipped Euro 2020 semi to donate stem cellson July 8, 2021 at 7:24 pm
Sam Astley, a 24-year-old technology buyer, turned down the chance to see England beat Denmark at Wembley to donate stem cells at a London hospital. But now, after a social media campaign, he is going ...
- Qualcomm’s 5G Open RAN Platform Elevates 5G Small Cell Technologyon July 8, 2021 at 4:00 pm
Small cell technology is becoming increasingly important as 5G continues its rollout, but why is that and what role is Qualcomm taking?
- Sandia-led center to advance understanding of new solar panel technologyon July 8, 2021 at 8:55 am
This means perovskite-based solar panels have the potential to be significantly cheaper and less energy-intensive to manufacture compared with silicon solar cells. However, perovskite-based ...
- This Cryogenic Stem Cell Cream Might Be the Closest Thing to Aging Backwardson July 7, 2021 at 11:48 am
This cryogenic stem cell cream from SkinPro could be the next big thing in anti-aging skincare — find out more ...
- Global Stem Cell Antibody Market Size by Production, Top Countries Import-Export and Consumption Forecast & Regional Analysis by 2025on July 7, 2021 at 8:16 am
GenScript (US), PerkinElmer, Inc (US) ,Lonza (Switzerland), and BioLegend, Inc (US) Market Overview: The global Stem Cell Antibody market is anticipated to rise at a considerable rate during the ...
- Exercise prompts cells to react in a way that could protect against bone cancer and other bone-related illnesseson July 7, 2021 at 6:12 am
Scientists at Nottingham Trent University say that such occurrences in the bone cells is also likely to play an important role in helping to limit the risk of other bone illnesses, such as ...
- 5G Small Cells: Five Opportunities For Enterpriseon July 7, 2021 at 5:40 am
Unlike Wi-Fi access points, 5G small cells are built on 3GPP mobile technology, ensuring seamless hand-off between small cells with no connectivity loss. This is critical for use cases such as ...
- University of Technology Sydney: Lighting up a street view of human cellson July 7, 2021 at 12:17 am
Australian Laureate Fellowship, worth almost $2.8 million over five years, to further develop optical nanotechnologies for imaging living cells down to the level of subcellular compartments ...
- New technology detects greater variety of T cells that respond to coronaviruseson June 30, 2021 at 9:00 pm
Scientists have developed a new technology to detect a wider variety of T cells that recognize coronaviruses, including SARS-CoV-2.
The Latest Google Headlines on:
Stem cell technology
The Latest Bing News on:
Regenerative therapies for spinal cord injuries and diseases
- Spinal Injury Repair Possible by Targeting 'Zombie Cells'on July 6, 2021 at 11:24 am
Administration of drugs that target specific cellular components of complex scar may improve functional recovery after spinal cord injury.
- New treatment targeting senescent cells boosts functional recovery from spinal cord injuryon July 6, 2021 at 4:37 am
Senescent cells prevent tissue recovery following spinal cord injury, and a new drug targeting these cells could therefore improve functional recovery capacity.
- Lineage’s OPC1 Cell Therapy for the Treatment of Spinal Cord Injury to Return to Clinical Testingon June 22, 2021 at 7:50 am
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today provided an update on the ...
- Lineage’s OPC1 Cell Therapy for the Treatment of Spinal Cord Injury to Return to Clinical Testingon June 22, 2021 at 5:50 am
Following feedback received from an interaction held with the U.S. Food and Drug Administration (FDA) last week under the FDA’s Regenerative ... treatment of patients with spinal cord injury.
- Lineage’s OPC1 Cell Therapy for the Treatment of Spinal Cord Injury to Return to Clinical Testingon June 22, 2021 at 3:52 am
transplant therapy for the treatment of spinal cord injury (SCI). Following feedback received from an interaction held with the U.S. Food and Drug Administration (FDA) last week under the FDA’s ...
- A New microRNA Target for Treating Spinal Cord Injurieson June 9, 2021 at 3:00 am
In vitro treatment ... spinal cord injury. Collectively, these results demonstrate that miR-31 plays a key regulatory role in neural development and promotes the neural repair. Dr. Wang said ...
- Omega-3 Fatty Acids: Their Neuroprotective and Regenerative Potential in Traumatic Neurological Injuryon June 2, 2021 at 5:00 pm
Spinal cord injury (SCI) and traumatic brain injury (TBI) have dramatic consequences, and no neuroprotective or neuroregenerative treatment ... for a broad spectrum of diseases.
- Spinal Cord Injuryon May 27, 2021 at 5:00 pm
A team of specialists in regenerative rehabilitation ... injection for rotator cuff disease in wheelchair users with spinal cord injury. ... Using metagenomic sequencing, researchers have ...